Merck & Company, Inc. (
) will begin trading ex-dividend on March 13, 2013. A cash dividend
payment of $0.43 per share is scheduled to be paid on April 05,
2013. Shareholders who purchased MRK stock prior to the ex-dividend
date are eligible for the cash dividend payment. This represents an
2.38% increase over the same period a year ago.
The previous trading day's last sale of MRK was $42.97,
representing a -10.48% decrease from the 52 week high of $48 and a
16.07% increase over the 52 week low of $37.02.
MRK is a part of the Consumer Durables sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). MRK's current earnings per share, an indicator of a company's
profitability, is $2.16. Zacks Investment Research reports MRK's
forecasted earnings growth in 2013 as -4.73%, compared to an
industry average of -.1%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to MRK through an Exchange
Traded Fund [ETF]?
The following ETF(s) have MRK as a top-10 holding:
- First Trust Morningstar Dividend Leaders Index Fund (
- Select Sector SPDR Fund - Health Care (
- Vanguard Health Care ETF (
- iShares Dow Jones U.S. Pharmaceutical Index Fund (
- iShares Dow Jones U.S. Health Care Index Fund (
The top-performing ETF of this group is XLV with an increase of
10.41% over the last 100 days. FDL has the highest percent
weighting of MRK at 7.76%.